SKYE BIOSCIENCE INC (SKYE) Stock Price, Quote, News and Overview
NASDAQ:SKYE - Nasdaq - US83086J2006 - Common Stock - Currency: USD
SKYE Quote, Performance and Key Statistics
SKYE BIOSCIENCE INC
NASDAQ:SKYE (2/11/2025, 8:00:01 PM)
After market: 2.98 +0.09 (+3.11%)2.89
-0.54 (-15.74%)
The current stock price of SKYE is 2.89 USD. In the past month the price increased by 3.21%.
SKYE Latest News and Analysis
Tuesday's session: top gainers and losers
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Skye Bioscience Announces Participation in February Conferences
SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on...
Skye Bioscience Provides 2025 Look Ahead and Year in Review
Expected Phase 2 obesity data in Q2 2025 and Q4 2025 will shape clinical potential and development path of distinctive CB1 inhibitor...
Skye Bioscience to Present at J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on...
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on...
Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company...
SKYE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.96 | 338.99B | ||
| AMGN | AMGEN INC | 14.97 | 159.46B | ||
| GILD | GILEAD SCIENCES INC | 21.7 | 119.82B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1569.72 | 117.23B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.58 | 73.13B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.03B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.69B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.45B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.57B | ||
| NTRA | NATERA INC | N/A | 22.41B | ||
| BIIB | BIOGEN INC | 8.54 | 20.31B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.77B |
Related stock screener links
About SKYE
Company Profile
Skye Bioscience, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of cannabinoid-based therapeutics. The company is headquartered in San Diego, California and currently employs 11 full-time employees. The company went IPO on 2014-02-24. The firm's clinical assets focus on the modulation of cannabinoid receptor 1 (CB1) to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. Its Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion (SBI-100 OE), a CB1 agonist (activator), being developed for the treatment of glaucoma and ocular hypertension. The firm's Phase 2 study in obesity is designed to evaluate nimacimab's weight loss potential either as a single agent or in combination with a glucagon-like peptide-1 (GLP-1) agonist like semaglutide.
Company Info
SKYE BIOSCIENCE INC
11250 El Camino Real, Suite 100
San Diego CALIFORNIA US
Employees: 11
Company Website: https://skyebioscience.com/
Investor Relations: http://ir.skyebioscience.com
Phone: 18584100266
SKYE FAQ
What is the stock price of SKYE?
The current stock price of SKYE is 2.89 USD.
What is the symbol for SKYE BIOSCIENCE INC stock?
The exchange symbol of SKYE BIOSCIENCE INC is SKYE and it is listed on the Nasdaq exchange.
On which exchange is SKYE stock listed?
SKYE stock is listed on the Nasdaq exchange.
Is SKYE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for SKYE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of SKYE.
Does SKYE stock pay dividends?
SKYE does not pay a dividend.
What is the Price/Earnings (PE) ratio of SKYE?
SKYE does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.11).
What is the Short Interest ratio of SKYE stock?
The outstanding short interest for SKYE is 6.34% of its float.
SKYE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SKYE.
SKYE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SKYE. While SKYE has a great health rating, there are worries on its profitability.
SKYE Financial Highlights
Over the last trailing twelve months SKYE reported a non-GAAP Earnings per Share(EPS) of -1.11. The EPS increased by 90.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.05% | ||
| ROE | -28.02% | ||
| Debt/Equity | 0 |
SKYE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to SKYE. The Buy consensus is the average rating of analysts ratings from 12 analysts.